NCT03485014View on ClinicalTrials.gov

Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 10, 2018

Primary Completion Date

February 12, 2019

Study Completion Date

February 12, 2019

Conditions
Postoperative Pain Management
Interventions
DRUG

Exparel

EXPAREL 4 mg/kg

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY